πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 401 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8673300

Therapeutic compositions and methods for the prevention of autoimmune diseases

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8652475

Inhibition of factor B, the alternative complement pathway and methods related thereto

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8642614

Toll-like receptor modulators and uses thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8637239

Minimally-invasive measurement of esophageal inflammation

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8633034

Methods for evaluating the aggregation of a protein in a suspension including organopolysi

The Regents of the University of Colorado Β· Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8623917

Uses of prostacyclin analogs

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8613904

Methods for diagnosis and intervention of hepatic disorders

The Regents of the University of Colorado Β· Granted Tue Dec 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8598133

Methods for treating pain

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8575170

Flurbiprofen analogs and methods of use in treating cancer

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8569225

Targeting complement factor H for treatment of diseases

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8563515

Tight junction protein modulators and uses thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8557764

Methods of modulating immune function

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8551964

Hsp90 inhibitors with modified toxicity

The Regents of the University of Colorado Β· Granted Tue Oct 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8540997

Complement receptor 1 and 2 fusion proteins

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8524678

Method for delivering genes

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8519086

Degradable thiol-ene polymers

The Regents of the University of Colorado Β· Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8507195

MiRNAs dysregulated in triple-negative breast cancer

The Regents of the University of Colorado Β· Granted Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8465737

Three-dimensional structure of complement receptor type 2 and uses thereof

The Regents of the University of Colorado Β· Granted Tue Jun 18 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8455565

Disulfide monomers comprising ethylenically unsaturated groups suitable for dental composi

The Regents of the University of Colorado Β· Granted Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8454977

Non-toxic biofilm inhibitor

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8444991

Method of preparing an immunologically-active adjuvant-bound dried vaccine composition

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8431626

Disulfide monomers comprising ethylenically unsaturated norbornyl groups suitable for dent

The Regents of the University of Colorado Β· Granted Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8404650

Methods of treating cancer with doxazolidine and prodrugs thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8398989

Human cystathionine Ξ²-synthase variants and methods of production thereof

The Regents of the University of Colorado Β· Granted Tue Mar 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted